Literature DB >> 22446383

The role of CUGBP1 in age-dependent changes of liver functions.

Karlie Jones1, Lubov Timchenko, Nikolai A Timchenko.   

Abstract

Aging liver is characterized by alterations of liver biology and by a reduction of many functions which are important for the maintenance of body homeostasis. The main dysfunctions include appearance of enlarged hepatocytes, impaired liver regeneration after partial hepatectomy (PH), development of hepatic steatosis, reduction of secretion of proteins and alterations in the hepatic sinusoid. RNA binding proteins are involved in the regulation of gene expression in all tissues including regulation of biological processes in the liver. This review is focused on the role of a conserved, multi-functional RNA-binding protein, CUGBP1, in the development of aging phenotype in the liver. CUGBP1 has been identified as a protein which binds to RNA CUG repeats expanded in Myotonic Dystrophy type 1 (DM1). CUGBP1 is highly expressed in the liver and regulates translation of proteins which are critical for maintenance of liver functions. In livers of young mice, CUGBP1 forms complexes with eukaryotic translation initiation factor eIF2 and supports translation of C/EBPβ and HDAC1 proteins, which are involved in liver growth, differentiation and liver cancer. Aging changes several signaling pathways which lead to the elevation of the CUGBP1-eIF2α complex and to an increase of translation of C/EBPβ and HDAC1. These proteins form multi-protein complexes with additional transcription factors and with chromatin remodeling proteins causing epigenetic alterations of gene expression in livers of old mice. It appears that CUGBP1-mediated translational elevation of HDAC1 is one of the key events in the epigenetic changes in livers of old mice, leading to the development of age-associated dysfunctions of the liver. This review will also discuss a possible role of CUGBP1 in liver dysfunction in patients affected with DM1.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446383      PMCID: PMC3610417          DOI: 10.1016/j.arr.2012.02.007

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  76 in total

1.  Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.

Authors:  Polina Iakova; Samir S Awad; Nikolai A Timchenko
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

2.  Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.

Authors:  Eun Ju Bae; Sang Geon Kim
Journal:  Mol Pharmacol       Date:  2005-06-16       Impact factor: 4.436

3.  CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding.

Authors:  Julien Marquis; Luc Paillard; Yann Audic; Bertrand Cosson; Olivier Danos; Christine Le Bec; H Beverley Osborne
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

4.  Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA.

Authors:  A L Welm; S L Mackey; L T Timchenko; G J Darlington; N A Timchenko
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 5.  Aging and regional differences in fat cell progenitors - a mini-review.

Authors:  Anna Sepe; Tamara Tchkonia; Thomas Thomou; Mauro Zamboni; James L Kirkland
Journal:  Gerontology       Date:  2010-01-29       Impact factor: 5.140

6.  Elimination of C/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice.

Authors:  Guo-Li Wang; Xiurong Shi; Simon Haefliger; Jingling Jin; Angela Major; Polina Iakova; Milton Finegold; Nikolai A Timchenko
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

Review 7.  Age-related changes in liver structure and function: Implications for disease ?

Authors:  Douglas L Schmucker
Journal:  Exp Gerontol       Date:  2005 Aug-Sep       Impact factor: 4.032

8.  The influence of age, liver size and enantiomer concentrations on warfarin requirements.

Authors:  H Wynne; L Cope; P Kelly; T Whittingham; C Edwards; F Kamali
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

9.  Mechanism of the internal ribosome entry site-mediated translation of serine hydroxymethyltransferase 1.

Authors:  Jennifer T Fox; Patrick J Stover
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

10.  SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.

Authors:  Derek M Erion; Shin Yonemitsu; Yongzhan Nie; Yoshio Nagai; Matthew P Gillum; Jennifer J Hsiao; Takanori Iwasaki; Romana Stark; Dirk Weismann; Xing Xian Yu; Susan F Murray; Sanjay Bhanot; Brett P Monia; Tamas L Horvath; Qian Gao; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

View more
  17 in total

1.  FXR-Gankyrin axis is involved in development of pediatric liver cancer.

Authors:  Leila Valanejad; Kyle Lewis; Mary Wright; Yanjun Jiang; Amber D'Souza; Rebekah Karns; Rachel Sheridan; Anita Gupta; Kevin Bove; David Witte; James Geller; Gregory Tiao; David L Nelson; Lubov Timchenko; Nikolai Timchenko
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

2.  p300 Regulates Liver Functions by Controlling p53 and C/EBP Family Proteins through Multiple Signaling Pathways.

Authors:  Meghan Breaux; Kyle Lewis; Leila Valanejad; Polina Iakova; Fengju Chen; Qianxing Mo; Estela Medrano; Lubov Timchenko; Nikolai Timchenko
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

Review 3.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.

Authors:  Kyle Lewis; Leila Valanejad; Ashley Cast; Mary Wright; Christina Wei; Polina Iakova; Lauren Stock; Rebekah Karns; Lubov Timchenko; Nikolai Timchenko
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

5.  CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers.

Authors:  Haijiao Lu; Zhuang Yu; Shihai Liu; Lianhua Cui; Xiaozheng Chen; Ruyong Yao
Journal:  Med Oncol       Date:  2015-02-21       Impact factor: 3.064

6.  The perinucleolar compartment associates with malignancy.

Authors:  Yiping Wen; Chen Wang; Sui Huang
Journal:  Front Biol (Beijing)       Date:  2013-08-01

7.  Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancer.

Authors:  Jingling Jin; Polina Iakova; Yanjun Jiang; Kyle Lewis; Emily Sullivan; Nicole Jawanmardi; Lawrence Donehower; Lubov Timchenko; Nikolai A Timchenko
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

8.  RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.

Authors:  Gena Huang; Chen Song; Ning Wang; Tao Qin; Silei Sui; Alison Obr; Li Zeng; Teresa L Wood; Derek Leroith; Man Li; Yingjie Wu
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

9.  Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.

Authors:  Il-Hwa Hong; Kyle Lewis; Polina Iakova; Jingling Jin; Emily Sullivan; Nicole Jawanmardi; Lubov Timchenko; Nikolai Timchenko
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

10.  RNA-binding proteins regulate the expression of the immune activating ligand MICB.

Authors:  Sven Diederichs; Ofer Mandelboim; Daphna Nachmani; Tony Gutschner; Adi Reches
Journal:  Nat Commun       Date:  2014-06-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.